throbber
||||I||l||||||||illlllllllllllll|ll||Illlllllllllllllllllllllllllllllllllll
`USO05558083A
`
`United States Patent
`
`[19]
`
`[11] Patent Number:
`
`5,558,083
`
`Bathe et al.
`
`[45] Date of Patent:
`
`Sep. 24, 1996
`
`[54] NITRIC OXIDE DELIVERY SYSTEM
`
`FOREIGN PATENT DOCUMENTS
`
`[75]
`
`Inventors: Duncan P. L. Bathe, Madison; Thomas
`S. Kohlmann, McFarland; John R.
`Pinkert, Madison; Robert Q. Thain,
`Middleton, all of Wis.
`
`[73] Assignee: Ohmeda Inc., Liberty Corner, N.J.
`
`[21] Appl. No.: 156,175
`
`[22]
`
`Filed:
`
`Nov. 22, 1993
`
`Int. Cl.6 .................................................. .. A61M 15/00
`[51]
`[52] U.S. Cl.
`................................ 128/203.12; 128/203.14;
`128/203.25
`
`[58] Field of Search ......................... 128/202.22, 203.12,
`128/203.14, 203.25, 205.23
`
`[56]
`
`References Cited
`U.S. PATENT DOCUMENTS
`
`4,127,121
`4,191,952
`4,328,823
`4,336,798
`4,345,612
`4,442,856
`4,511,590
`4,770,168
`5,159,924
`5,197,462
`
`............. 128/203.14
`11/1978 Westenskow et al.
`.. 128/203.14
`3/1980 Schreiber et al.
`'128/203.14
`5/1982 Schreiber
`128/205.23
`6/1982 B
`..... ..
`__ 128/203.14
`8/1982 Kirnainet a1_
`128,2O2_22
`4/1984 Bea ___________._
`__ 123/20314
`9/1935 Ryschka at 31
`.. 128/203.14
`9/1988 Rusz et al.
`..... ..
`.. 128/203.25
`11/1992 Cegielski et al.
`3/1993 Falb et al.
`.......................... 128/203.14
`
`
`
`Canada .
`2121384 of 1994
`4325319
`of 1994
`Germany .
`W092/11052 of 1992 WIPO .
`W092/10228 of 1992 WIPO .
`
`OTHER PUBLICATIONS
`
`The Journal of Clinical Investigation, vol. 90, No. 2, Aug.
`1992, pp. 421-428.
`
`Primary Exami'ner—-Aaron J. Lewis
`Attorney, Agent, or Firm—Roger M. Rathbun; R. Hain
`Swope; Larry R. Cassett
`
`[57]
`
`ABSTRACT
`
`A nitric oxide delivery system that is useable with any of a
`variety of gas delivery systems that provide breathing gas to
`a patient. The system detects the flow of gas delivered from
`the gas delivery system at various times and calculates the
`flow of a stream of nitric oxide in a diluent gas from a gas
`control valve. The flow of gas from the gas delivery system
`and the flow established from the flow control valve create
`
`'
`
`a mixture having the desired concentration of nitric oxide for
`the patient
`
`.
`.
`The system does not have to interrogate the particular gas
`delivery system being used but is an independent system that
`can be used with various flows; flow profiles and the like
`from gas delivery systems.
`
`27 Claims, 2 Drawing Sheets
`
`F"F:::::::::::::::::::::::""1
`I
`L , —
`I“ '" " " 21222221222122‘ 7 7
`I
`|
`1
`L 53
`E
`r‘ ——————— ~ — -1 S}
`1
`{
`I
`67
`{*5}
`n'’°
`[-72
`iii»:
`NOIN2
`|
`SUPPLY
`54 _
`: 24
`g
`:
`, N0
`[2
`[SENSOR — Q — u——“—*‘~-—
`'- "I J
`1 . - 1
`n :
`I -_ i 9-
`r‘ -
`lo
`20
`22
`I
`
`|
`
`I4
`
`CPU
`
`_
`
`1
`‘
`E
`r- 1 I
`1
`I = I
`I7
`
`1
`
`1
`
`160 N=uT DEVICE
`I. _ _ _/ L. ._ _.l
`30 I
`
`_
`
`I
`
`58
`
`,7
`
`55
`_ _ _ _ _ _ W
`
`I
`
`}
`
`5
`
`GAS SENSING BENCH
`52
`
`48
`\v
`50 Q 32
`
`44
`
`2
`
`38
`
`34
`
`«:9 36
`4o
`
`42
`
`001
`
`PRAXAIR 1005
`
`001
`
`

`
`U.S. Patent
`
`Sep.24, 1996
`
`Sheet 1 of 2
`
`5,558,083
`
`xozmmozazmmm<o_onuan47IJWIILI_
`“uosmo5%.ow_._r\mm“mm$;_”_mm0mm-Iom2o_
`
`
`PLI.I_|IIIIIIEuILI04mnm_\_f..Ia
`moIIJIIIILInlImowzmm_N.
`
`_____3N252__I_.
`IvmEnnnoz_Sn_%m
`
`
`
`____"I«Qof8;m_____IIIIIIIII4__fl._I_.IIIIIIHHHHIIIIHHIIHIIII._IIILmm,L__IIIlIH.IHIIHIIHIhIIUlHHH.WIIHI.HIHI.H.IHIH..WI“IW|INI.HWlI.mI|IH_IIL
`
`O02
`
`m¢_ans2
`mmonmm>._&mm
`
`Nn.‘Oon0.4'_H29»1vHI
`
`w.j
`
`002
`
`

`
`U.S. Patent
`
`Sep. 24, 1996
`
`Sheet 2 of 2
`
`5,558,083
`
`
`
`xozmmozmzmmm<o
`
`mm
`
`NGE
`
`
`
`mo_>mo._.Dn_Z_om___I__CIN__I8
`IIL5-___III|IIIIIIIIII|II|II|Ill.L
`NM,ofi__\z_____IlllllllllI_(_mm-z_mm__“I_I_...HHlIHIIH.n.IIII|IIIIII|..IILI
`ulom...__o_L HIH1.n.Eu'.‘'_rt
`on_IIJWIII»._&:mLaIIIIIIIIIIIII;nmz
`mmmmourmm4>._%_m.w
`we_EmowE_u
`II:/_\|I|/\|I_mm.mm
`IIJIIIILI"II_~_
`A‘pl_owJV_Q9$X‘9:__uI_._on_—_IuLjITI...
`
`INuuu_,%_n_mm
`
`mm.’onom-;_III
`
`003
`
`003
`
`

`
`5,558,083
`
`2
`
`1
`NITRIC OXIDE DELIVERY SYSTEM
`
`BACKGROUND OF THE INVENTION
`
`to
`The administration of inhaled nitric oxide (NO)
`patients is currently being investigated for its therapeutic
`effect. The use of NO has a vasodilatory effect on such
`patients and is particularly of importance in the case of
`newborns having persistent pulmonary hypertension.
`In
`such cases,
`the administration of NO has significantly
`increased the oxygen saturation in such infants.
`\
`The function of the administration of NO has been fairly
`widely published and typical articles appeared in The Lan-
`cet, Vol. 340, October 1992 at pages 818-820 entitled
`“Inhaled Nitric Oxide in Persistent Pulmonary Hypertension
`of the Newborn” and “Low-dose Inhalational Nitric Oxide
`in Persistent Pulmonary Hypertension of the Newborn” and
`in Anesthesiology, Vol. 78, pgs. 413-416 (1993), entitled
`“Inhaled NO—the past, the present and the future”.
`The actual adnrinistration of NO is generally carried out
`by its introduction into the patient as a gas along with other
`normal inhalation gases given to breathe the patient. Such
`commercially available supplies are provided in cylinders
`under pressure and may be at pressures of about 2000 psi
`and consist of a nrixture of NO in nitrogen with a concen-
`tration of N0 of between about 800-2000 ppm. As such,
`therefore, some means must be used to reduce the pressure
`of the supply to acceptable levels for a patient and also to
`very precisely meter the amount of the NO and nitrogen
`mixture so that the desired concentration of NO is actually
`administered to the patient. Such administration must also
`be added in sympathy with the respiration pattern of the
`patient.
`The concentration administered to a patient will vary
`according to the patient and the need for the therapy but will
`generally include concentrations at or lower than 150 ppm.
`There is, of course, a need for that concentration to be
`precisely metered to the patient since an excess of NO can
`be harmful
`to the patient. In addition, the administration
`must be efficient in a timely manner in that NO is oxidized
`in the presence of oxygen to nitrogen dioxide and which is
`a toxic compound. Therefore, care in its administration is
`paramount.
`Current known methods of such administration, therefore
`have been limited somewhat to clinical situations where
`attending personnel are qualified from a technical sense to
`control the mixing and administration of the NO to a patient.
`Such methods have included the use of a forced ventilation
`device, such as a mechanical ventilator where a varying flow
`os breathing gas is delivered to the patient as well as gas
`blenders or proportioners that supply a continuous flow of
`the breathing gas to the patient to which NO has been added.
`In the former case, the use of a ventilator is constrained
`in that
`the user must know the precise flow from the
`ventilator and then the amount of NO to be added is
`determined on a case-to-ease and moment-to-moment basis.
`Furthermore, the flow profile in forced ventilation varies‘
`continuously thereby making it impossible to track the flow
`manually. In the use of the latter gas blenders, the introduc-
`tion of the NO containing nitrogen has been accomplished
`through the use of hand adjustment of the gas proportioner
`in accordance with a monitor that reads the concentration of
`NO being administered to the patient. Thus the actual
`concentration is continuously being adjusted by the user in
`accordance with the ongoing conditions of the apparatus
`providing the breathing mixture.
`
`5
`
`While such modes of providing a known concentration of
`NO to the patient may be acceptable from a closely con-
`trolled and monitored clinical setting, it is advantageous to
`have a system that could be used with various means of
`providing the breathing gas, whether by mechanical means
`such as a ventilator, or by the use of a gas proportioner and
`which could automatically adjust for that particular equip-
`ment and assure the user that the desired, proper concentra-
`tion of NO is being administered to the patient.
`
`SUMMARY OF THE INVENTION
`
`In accordance with the present invention, there is pro-
`vided a nitric oxide delivery system that is useable with
`various means of administering the NO, including the use of
`any mechanically assisted ventilation and ventilatory pat-
`tern, such as a ventilator or with spontaneous ventilation
`where the NO is introduced by means of a gas proportioning
`device that provides a continuous fiow to the patient. The
`invention includes a flow transducer that senses the flow of
`gas from the gas delivery system and uses that information
`with a selective algorithm to provide an operator selectable
`concentration of NO to the patient. As used herein, the term
`gas delivery system is intended to include various types of
`gas proportioning devices, gas mixers and various types of
`mechanical ventilators used to provide breathing gas to a
`patient and may include an anesthesia machine, or manual
`bag, used with a patient undergoing an operation and which
`has a fresh gas supply.
`In the preferred embodiment, a CPU obtains information
`from the flow transducer and from an input device that
`allows the user to select the desired concentration of NO to
`be delivered to the patient and calculates the flow of NO/ni-
`trogen to obtain that selected concentration. It will be noted,
`however, that while a CPU is preferred, the signal process-
`ing needed by this system can readily be accomplished
`through the use of alternate technologies, such as analog or
`digital circuitry, lluidic circuits, optical means or mechanical
`components. The
`term “signal processing means” is
`intended to encompass the variety of ways that may be
`utilized to carry out the various signal processing functions
`toopcrate the subject NO delivery system.
`Accordingly, the present system can be used with preci-
`sion with various gas delivery systems, including ventilators
`of different manufacturers operating with diverse ventilatory
`patterns without
`the need to calculate output from the
`ventilator,
`to interrogate the gas delivery means, or to
`regulate the concentration manually. The user is thus free to
`concentrate on other procedures that will
`improve the
`patient.
`By use of the CPU, various algorithms may be stored and
`used as appropriate. For example, there may be one algo-
`rithm that is used to obtain a steady concentration of NO in
`a spontaneous or continuous flow situation such as when a
`gas proportioner of gas blender is used. A differing use of
`that same algorithm may be used to achieve an instantaneous
`change in the NO/nitrogen supply flow to maintain the
`desired flow to the patient or, that same algorithm may be
`used to calculate a breath-by-breath flow of NO/nitrogen
`such that the flow from the gas delivery system may be
`determined and used to adjust the NO/nitrogen flow to
`maintain the desired NO concentration to the patient in the
`next breath delivered to the patient. In any manner, the CPU
`takes over the manual setting of any valves and established
`the concentration of NO to the patient as set or selected by
`the user.
`
`20
`
`25
`
`30
`
`35
`
`40
`
`45
`
`50
`
`55
`
`60
`
`65
`
`004
`
`004
`
`

`
`3
`
`4
`
`5,558,083
`
`Another use of the preferred signal processor, the CPU, is
`to supervise the safe operation of the NO delivery system by
`providing alarm functions and other functions to protect the
`patient in the event of faults in the delivery of NO.
`As an alternate embodiment, a further means is included
`that adjusts the 02 concentration to the patient to compen-
`sate for the diminution of O2 to the patient as the patient
`inspiratory gas is loaded with NO/nitrogen to achieve a
`specified concentration of NO in the patients inspired gases.
`As a still further embodiment, a purge system is included
`that is activated to purge the various components and to fill
`the system with a gas having a known nitric oxide concen-
`tration from the supply.
`The system also includes various controls, alarms and
`safety devices to prevent excess concentrations of N02 in
`the administration of NO to the patient, including means to
`shut down the NO system or to reduce the NO concentration
`to the patient to a safer level. The NO delivery system may
`thus provide an alarm or other appropriate action in the event
`of an increase in the NO level beyond a predetermined level,
`a decrease in 02 below a predetermined level and/or an
`increase of N02 above a predetermined level. Depending on
`the severity of the alarm condition, an alarm may sound or
`the entire system may be controlled to alleviate the unsafe
`condition sensed.
`
`These and other objects, features and advantages of the
`present invention will be more apparent from the detailed
`description of the preferred embodiment set forth below,
`taken in conjunction with the accompanying drawings.
`
`BRIEF DESCRIPTION OF THE DRAWINGS
`
`10
`
`15
`
`20
`
`25
`
`30
`
`FIG. 1 is a schematic view, partially in block diagram
`form, of apparatus in accordance with an embodiment of the
`present invention.
`
`35
`
`FIG. 2 is a schematic view, partially in block diagram
`from, of apparatus in accordance with another embodiment
`of the present invention.
`
`DETAILED DESCRIPTION OF THE
`PREFERRED EMBODIMENTS
`
`Turning first to FIG. 1, there is shown a schematic view,
`partially in block diagram form, showing an apparatus
`constructed in accordance with the present invention. In the
`FIG. 1, a supply of nitric oxide is provided in the form of a
`cylinder 10 of gas. That gas is preferably nitric oxide mixed
`with nitrogen and is a commercially available mixture.
`Although the preferred embodiment utilizes the present
`commercial NO/nitrogen mixture, it is obvious that the NO
`may be introduced to the patient via some other gas,
`preferably an inert gas. Generally, of course, the cylinder 10
`of nitric oxide is delivered pressurized and a typical pressure
`is on the order of about 2000 psi with a concentration of
`nitric oxide in the order of about 1000 ppm. Alternatively,
`the NO/nitrogen gas may be available in a central supply
`within a hospital and be available through the normal
`hospital piping system to various locations such as operating
`rooms. In such case, the pressure may already be reduced to
`a relatively lower amount that the cylinder pressures.
`A pressure regulator 12 is used, therefore, to reduce the
`pressure of the gas in cylinder 10 down to acceptable levels
`for operation of the system, and again, typically, the regu-
`lator 12 reduces the pressure to about 40 psi or lower. An
`on—off shutoff valve 14 receives the reduced pressure gas
`from regulator 12 through a suitable conduit and is prefer-
`ably solenoid operated. The use and purpose of the shutoff
`
`40
`
`45
`
`50
`
`55
`
`60
`
`65
`
`valve 14 will later be explained in conjunction with the
`operation of the nitric oxide delivery system.
`A separate supply of pure nitrogen may be employed and,
`again, generally is provided by a cylinder 16 of nitrogen
`although pipeline nitrogen is available in numerous hospi-
`tals. The pressure of the nitrogen within cylinder 16 is
`reduced to the desired system level by means of regulator 17
`and the nitrogen thereafter supplied via a conduit
`to a
`proportional control valve 18 that is controlled in a manner
`to be described. Suffice at this point is to state that the
`proportional control valve 18 provides a predetermined flow
`of nitrogen through a suitable conduit into the conduit to be
`mixed with the NO/nitrogen gas from cylinder 10 and which
`then enters the shutoff valve 14.
`
`The purpose of the additional supply of nitrogen is to
`dilute, if necessary, the concentration of nitric oxide in the
`supply to the shutofl valve 14 to a desired amount. For
`example, the cylinder 10 may be supplying a concentration
`of nitric oxide that is too high for the particular flows in the
`system and therefore the concentration may be reduced to a
`more desirable level. If, of course, the supply of nitric oxide
`from cylinder 10 is suitable for the particular application, the
`addition of supplemental nitrogen is unnecessary.
`Further downstream in the conduit carrying the NO/ni-
`trogen stream is a purge valve 20 and which may be a
`solenoid operated valve that diverts the stream of NO/nitro-
`gen from shutoff valve 14 to a sidestream 22 where the
`mixture is removed from the environment by means of a
`hospital evacuation or other system to remove such gases.
`Such system may, of course, have various treatment means
`such as a NO2 and NO scrubber 23 if required in a particular
`hospital.
`Again, the control of the purge valve 20 and its use will
`be later explained in connection with the overall operation of
`the nitric oxide delivery system, and which is optional.
`A further proportional control valve 24 is positioned with
`suitable conduit to receive the NO/nitrogen gas from the
`purge valve 20. Typical of such proportional control valves
`for both the proportional control valve 18 in the nitrogen
`supply system and the proportional control valve 24 in the
`NO/nitrogen stream may be obtained commercially from
`various companies,
`including MKS Instruments,
`Inc. of
`Andover, Mass. and which provide electronic control of
`gases. As may be seen, alternately, the valve may be a digital
`controlled valve rather that analog and which is controlled
`by timing its on/off cycles to eflect the desired flow through
`the proportional control of flow thcrethrough. Combination
`of several valves used singly or in combination can be used
`to extend the delivery range.
`A flow sensor 26 is located in the downstream conduit
`from proportional control valve 24 and senses the flow from
`such valve. Typically, in view of the values of flow at this
`point in the nitric oxide delivery system, the flow transducer
`may be of a technology such as the thermal mass llowmetcr
`available from MKS Instruments, Inc. or may be of other
`technology of other suppliers.
`A delivery adaptor 28 receives the NO/nitrogen gas via a
`suitable conduit for introduction into a further gas stream
`from the gas delivery system (not shown).
`Delivery adaptor 28 is preferably a one piece reusable
`device and which has an inlet 30 which receives the gas
`delivered from the gas delivery system. As indicated, that
`gas delivery system may be a mechanical means providing
`a varying flow such as a ventilator, may be gas continuously
`supplied by a gas proportioning device for spontaneous
`ventilation or may be gases supplied to a bag for manual
`
`O05
`
`005
`
`

`
`5
`
`6
`
`5,558,083
`
`ventilation. As can be seen, the actual gas delivery system
`itself is not critical since the present system independently
`ascertains the flow from that system and proceeds to calcu-
`late and then deliver the proper flow of nitric oxide to arrive
`at the concentration to the patient that is selected by the user.
`The delivery adaptor 28 has a main passage 32 there-
`through and which receives the gas from the gas delivery
`device through inlet 30 for delivery to a patient. The gas
`actually delivered to the patient is transmitted via a patient
`wye piece 34 having an inspiratory limb 36 and an expira-
`tory limb 38 of conventional design. The patient limb 40,
`obviously, leads to the patient indicated by the block 42.
`A further inlet 44 is formed in the delivery adaptor 28 and
`which receives the NO/nitrogen gas from the proportional
`control valve 24 through flow sensor 26-. As can be seen from
`FIG. 1, a flow transducer 46 is also included in the delivery
`adapter 28 and which detects the flow of gas from the gas
`delivery system. The inlet 44 is positioned downstream in
`the delivery adapter 28 from flow transducer 46. Flow
`transducer 46 may be of a variety of technologies, including
`pneumotach, hot wire anemometer,
`thermal flow sensor,
`variable orifice, thermal time—of—flight, rotating vane and the
`like. Included, obviously, are flow transducers that actually
`measure pressure, such as a pressure drop though an orifice,
`in order to determine flow.
`
`A sampling port 48 is formed in the delivery adapter 28
`and which communicates with the flow of gas passing
`through the main passage 32. It should be noted that the
`sampling port 48 thus samples the mixed gases, that is the
`gas downstream from the inlet 44 and thus downstream from
`a confluence 50 where the NO/nitrogen stream of gas is
`mixed with the inspiratory gas from the gas delivery system.
`Accordingly, the flow from the gas delivery means enters
`the inlet 30 at a flow rate Q, and at a certain concentration
`of oxygen yO2,. and is mixed in the main passage of delivery
`adapter 28 with the NO/nitrogen gas from proportional
`control valve 24 at confluence 50. Flow transducer 46 is
`upstream of the confluence 50 and thus senses the flow only
`of the gas from the gas delivery system while sampling port
`48 is downstream of the confluence S0 and thus provides
`access to samples of the gases that are mixed together at
`confluence 50. At confluence 50, there may be a diffuser
`such as a screen or sintered, porous block that enhances the
`' mixing of the NO/nitrogen with the gases from the gas
`delivery system.
`Therefore, the concentration of mixed gases at sampling
`port 48 contains the concentration of NO that actually enters
`the patient for therapeutic treatment and is the concentration
`set by the user, yNOS,_,,.
`Connected to the gas sampling port 48 is a gas sensing
`bench 52 and which analyzes the concentrations of certain
`components of the gas stream administered to the patient. In
`the preferred embodiment, the gas sensing bench 52 samples
`the gases through conduit 54 and senses and quantifies the
`concentration of NO as well as N02 and O2. Altemately, a
`sensor may be directly attached to the delivery adaptor 28
`and directly sense such gas passing through the main pas-
`sage 32.
`A signal processing means, such as a CPU 56 is provided
`to solve certain equations and algorithms to operate the
`nitric oxide delivery system. CPU 56 receives a signal from
`an input device 58 indicative of the concentration the user
`desires to be administered to the patient. CPU 56 also
`receives signals from the flow transducer 46 indicative of the
`flow of gas delivered by the gas delivery system, Q, through
`a signal line 60 and also receives signals indicative of the
`
`10
`
`15
`
`20
`
`25
`
`30
`
`35
`
`40
`
`45
`
`50
`
`55
`
`60
`
`65
`
`concentration of NO, as well as N02 and 02 from gas sensor
`bench 52 via a signal line 62 and a signal from flow sensor
`26 indicative of the flow from proportional control valve 24,
`QM, respectively via a signal line 64.
`Another input to CPU 56 is provided by the NO sensor 65
`through signal line 67. The NO sensor 65 senses the con-
`centration of NO in the supply cylinder 10 so that the user
`can verify that
`the proper supply is being utilized or,
`alternatively, the CPU 56 may use that input to adjust the
`system to adapt for any concentrations of NO in the supply
`within certain limits. NO sensor 65 could, of course, be
`eliminated if the NO cylinder 10 is always constant or by
`keying into the NO sensor in the gas sensing bench 52. A
`switching mechanism (not shown) would be required to
`sample from the multiple sources of samples.
`Control signals are transmitted from CPU 56 to propor-
`tional control valve 18, shutoff valve 14, purge valve 20, and
`proportional valve 24 via signal lines 66, 68, 70, and 72
`respectively.
`In the operation of the present NO delivery system,
`therefore, the inlet 30 is connected to a gas delivery system,
`whether that gas delivery system is a mechanical ventilator
`or gas proportioning device or other means of supplying a
`breathing gas to a patient. As the gas is delivered from the
`gas delivery system, its flow is sensed by the flow transducer
`46 in delivery adapter 28 and a signal is transmitted indica-
`tive of that flow to the CPU 56.
`
`The user activates the input device 58 to select the desired
`concentration of NO that is to be administered to the patient.
`That input device 58 may be of a variety of devices, such as
`a keyboard, dial, encoder, touch screen, thumb wheel or the
`like. Alternatively, the input may be a signal that is built into
`the delivery system by the manufacturer and not be select-
`able by the actual end user. For example, the delivery system
`may be designed to operate to provide a fixed concentration
`of NO and the use of the system with any gas delivery
`system would result in that fixed, predetermined concentra-
`tion of NO to be administered to the patient.
`In the preferred embodiment, however, the desired NO
`concentration to be administered to the patient is set by the
`user by means of an input to CPU 56.
`As can be seen, the CPU 56 has sufficient information to
`carry out the proper calculations, that is, it knows the flow
`of breathing gas from the gas delivery device by means of
`flow transducer 46 (Q,,) and the concentration of NO in the
`NO/nitrogen supply by means of NO sensor 65 (YNOM).
`With that information, CPU 56 can calculate the desired flow
`(QM) from the proportional control valve 24 that needs to be
`provided to the confluence 50 to mix with the gas from the
`gas delivery system to produce the desired or set concen-
`tration (yN0M) established by the user through input device
`58.
`
`Basically, CPU 56 calculates the flow of NO/nitrogen to
`be added to the confluence 50 through the following equa-
`tion;
`
`Q.:.l(t)={Y~o.....(t)/(rm...-v~o..e.(t)1*Ql(t)
`
`By this equation, the concentration of NO to the patient
`can be changed at an instantaneous rate limited only by the
`speed and sensitivity of the components such as flow trans-
`ducer 46. The faster the response of flow transducer 46 is,
`the faster changes can be made in flow of the NO/nitrogen
`to confluence 50 by proportional control valve 24 such that
`the NO to the patient can instantaneously account for
`changes in the flow profile from the gas delivery system to
`
`006
`
`006
`
`

`
`7
`
`8
`
`5,558,083
`
`maintain that concentration set by the user. The flow deliv-
`ered (Q,,,,) from the proportional control valve 24 to the
`confluence 50 is determined from the concentration set by
`the user, (YNOM). The concentration NOW, is the concen-
`tration of NO in nitrogen from the supply cylinder 10 and the
`flow from the gas delivery system is Q,.. By this equation, the
`CPU 56 can make extremely rapid, such as 20 millisecond,
`changes to the flow delivered from proportional control
`valve 24 (QM) in order to maintain the concentration of the
`flow delivered to the patient at the desired level as deter-
`mined by the user (ym).
`As an alternate, the system may operate on a breath—by-
`breath basis, that is, the system can take a reading of the
`flow, or a portion thereof, from the gas delivery system at
`each breath and calculate the desired flow of NO/nitrogen
`for delivery at the next breath. Although such delivery is less
`rapid than the instantaneous equation, slower flow transduc-
`ers and control valves may by employed and thus less
`expensive components used in the system. Therefore mean
`values can be used for the values set by the user (yN0,.,_,,,,,,_,_,,,,,)
`and the flow delivered by the proportional control valve 24
`(QM) is expressed as a function of the inspired tidal volume
`of gas (V,_,.,,_,I,_) and the time of inspiration (t,,,W). In such
`system, the equation is basically the same:
`
`Qde!:lYNO:u1.m:un/(YNocm‘YNom,mean) l * V1,irl:p./‘imp.
`
`With the breath—by-breath analysis, however, the flow
`transducer 46 may detect the start and end of a breath, or
`selected portion thereof, integrate to determine the total or
`fixed selected volume of the breath, and adjust the propor-
`tional control valve 24 to provide the set or desired concen-
`tration of NO at the next breath.
`
`For constant or continuous flow ventilation from the gas
`delivery system as might be provided by a gas mixer or
`proportioning device, the same basic equation is used:
`
`QderzlYNom/(YNauu‘YN0.m) l *Q.'
`
`In this case, however, since the flow is continuous and the
`tidal volume assure to be constant, the flow from the gas
`delivery system, (Q,.) may be sampled at a relatively slow
`rate, for example, once per second, and the flow of NO/ni-
`trogen calculated and established from proportional control
`valve 24 on that particular timing cycle.
`In any of the foregoing cases, the principal of operation is
`the same and the operative equation is basically the same.
`By knowing the flow from the gas delivery system by means
`of flow transducer 46 and the concentration of NO in the
`main supply from N0 sensor 65, a derivation is made by the
`CPU 56 and the proportional control valve 24 is adjusted to
`provide then calculated How of NO/nitrogen to arrive at the
`desired concentration set by the user in the breathing gas
`actually administered to the patient.
`Confirmation of the flow from the proportional control
`valve 24 is made by the flow sensor 26 so that CPU 56 can
`check to see of the actual flow corresponds to the flow
`calculated and established by the CPU 56 through signal line
`72 to proportional control valve 24. Alternatively, the flow
`sensor 26 can control the proportional control valve 24 using
`a feedback system and which is available in the commmer-
`cial valves from, for example, MKS Instruments Inc.
`As is also be apparent from FIG. 1, CPU 56 also controls
`the proportional control valve 18 via signal line 66 and can
`operate that valve to further reduce the concentration of the
`NO in nitrogen from cylinder 10 in the event very low
`concentrations are set by the user and the system is other-
`wise unable to reduce the concentration to the desired point.
`
`10
`
`20
`
`25
`
`30
`
`35
`
`40
`
`45
`
`SO
`
`55
`
`60
`
`65
`
`The gas sensing bench 52 provides a continuous monitor
`of the actual NO concentration administered to the patient
`and therefore is a further safety monitor. In the event the NO
`detected by the gas sensing bench 52 is a predetermined
`value away from the set point established by the user, an
`alarm may be triggered so the user can attend to the problem.
`In the event that the NO level rises to a dangerous level,
`CPU 56 will have that information and can take more drastic
`steps such as to discontinue use of the NO to the patient by
`shutting off the shutoff valve 14 or by automatically reduc-
`ing the NO level to a lower, safe level established in the
`system.
`As further alarms or triggers to actively change or termi-
`nate the NO system, the gas sensing bench 52 also monitors
`and provides the CPU 56 with a continuous reading of the
`concentrations of O2 and N02 being administered to the
`patient and, again, the CPU 56 can be programmed to take
`the appropriate action, be it trigger an alarm or reduce the
`NO concentration in the event the 02 level falls below a
`predetermined value or the N02 rises above a predetermined
`value.
`
`Finally, in the event of a loss of pressure in the supply at
`any time, CPU 56 can activate purge valve 20 to purge the
`system of any other gases that may be in the supply line and
`refill the supply lines from cylinder 10 to the purge valve 20
`with fresh NO/nitrogen. In this way, the system is recharged
`with the correct supply gas and no extraneous gases, such as
`ambient air, will be introduced into the system to cause error.
`Accordingly, through the use of the present NO delivery
`system, the concentration of NO delivered to the patient may
`be established, either by the selection by the user, or set by
`a predetermined value by the system itself, and that desired
`value will be transmitted to the patient without any interro-
`gation of the gas delivery device. The system is thus
`independent and may be readily used with any mechanical
`ventilator, gas proportioning device or other gas delivery
`system to deliver a known, desired concentration of NO to
`a patient.
`Turning briefly to FIG. 2, there is shown in schematic
`view, partially in block form, of another embodiment of the
`present NO delivery system. In FIG. 2, all of the corre-
`sponding components have been numbered with the same
`identification numbers as in FIG. 1.
`
`In this embodiment, however, an additional supplemental
`oxygen supply has been added by means of an oxygen
`cylinder 74 containing pressurized oxygen and which pres-
`sure is reduced by means of a regulator 76. Again it should
`be noted that the control of the oxygen supply is by means
`of a proportional control valve 78 which is controlled by the
`CPU 56 via a signal line 80.
`Thus the operation of the FIG. 2 embodiment is the same
`as previously explained with respect to the FIG. 1 embodi-
`ment however the supplemental oxygen system may be used
`to add oxygen to the system in the event the gas sensing
`bench 52 indicates to the CPU 56 that the concentration of
`oxygen has been reduced to an unacceptable level. Such
`reduction in oxygen could occur in the event the concen-
`tration of NO is set to a very high level and the flow of
`NO/nitrogen from proportional control valve 24 to conflu-
`ence 50 is very high and the combined flow to the patient
`thus is deprived of the needed amount of oxygen being
`supplied by the gas delivery system.
`In such event, the CPU 56 merely signals proportional
`control valve 78 to add or increase the flow of oxygen to the
`NO/nitrogen stream being admitted to confluence 50, that is,
`upstream of confluence 50 by means of a suitable conduit
`Numerou

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket